Código QR (código de barras bidimensional)

Latanoprostene Bunod 0.024% Early Experience Program (LEEP): A Canadian Initiative for Open-Angle Glaucoma and Ocular Hypertension

Abstract Introduction Here we report the intraocular pressure (IOP) changes following treatment with latanoprostene bunod (LBN) 0.024% in patients in Canadian ophthalmology practices. Methods This real-world, open-label, 6-week, observational study collected data from 59 Canadian ophthalmologists an...

Fuld beskrivelse

Na minha lista:
Principais autores: David Yan, Cindy M. L. Hutnik, Paul Harasymowycz
Format: Artigo
Sprog:Inglês
Udgivet: Adis, Springer Healthcare 2025-04-01
Serier:Ophthalmology and Therapy
Fag:
Intraocular pressure
Latanoprostene bunod
Open-angle glaucoma
Ocular hypertension
Nitric oxide donor
Patient satisfaction
Online adgang:https://doi.org/10.1007/s40123-025-01132-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker